Guillain-Barr syndrome risk greater after COVID-19, study indicates
A new study indicates that COVID-19 is associated with an elevated risk of a rare disorder, Guillain-Barr syndrome, within six weeks after infection with the virus.
A new study indicates that COVID-19 is associated with an elevated risk of a rare disorder, Guillain-Barr syndrome, within six weeks after infection with the virus.